GNI GROUP LTD.
Contact Us
About Us
About Us TOP
Message
Business Model
Main Products
Management Policy
Company Overview
Board of Directors
Main Group Structure
Office
Corporate governance
R&D
R&D TOP
Pipeline
Discovery Research
Research publications
Investor Relations
Investor Relations TOP
IR News
Information
IR Materials
IR Calendar
IR Email Subscription
Electronic Public Notices
Sustainability/ESG
Sustainability/ESG TOP
Sustainability Initiatives
ESG Data
Contact Us
Site Map
Privacy Policy
Terms of Use
ソーシャルメディアポリシー
Information
トップページ
Information
All
2026
2025
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2008/05/15
Announcement of the 7th Annual General Shareholder Meeting
2008/05/15
Notice of Issuance of Stock Options to Employees, Etc.
2008/05/08
GNI to present at IBC’s 3rd Annual International Conference and Exhibition
2008/05/07
IBC Drug Discovery & Development of Innovative Therapeutics Japan
2008/04/01
IBC China 2008 R&D Summit
2008/03/31
GNI and Organon Extend and Expand Collaborative Research
2008/03/31
The Journal “IDrugs” published a featured review article “China: Current trends in pharmaceutical drug discovery” on its March issue. In the article, the author Dr. Ying Luo summarized the history of drug discovery in China in the last two deca
2008/03/18
GNI Scientists Complete Three Grant Projects for Drug Target Discovery in China
2008/01/10
Nomura Securities’ New Year Greeting Party
2007/12/21
Phase I Human Trial of F351 Initiated in China
<
29
30
31
32
33
34
35
36
37
>